Antinociception opioids and the cholinergic system.
Green
P G
PG
Kitchen
I
I
D000109:Acetylcholine / Q000494:pharmacology / Q000502:physiology; D015670:Acupuncture Therapy; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004723:Endorphins / Q000502:physiology; D006801:Humans; D008959:Models, Neurological; D009388:Neostigmine / Q000378:metabolism / Q000494:pharmacology; D009434:Neural Pathways / Q000187:drug effects / Q000502:physiology; D010146:Pain / Q000503:physiopathology*; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D010277:Parasympathomimetics / Q000494:pharmacology; D010830:Physostigmine / Q000378:metabolism / Q000494:pharmacology; D011976:Receptors, Muscarinic / Q000187:drug effects; D011978:Receptors, Nicotinic / Q000187:drug effects
D000700:Analgesics; D002800:Cholinesterase Inhibitors; D004723:Endorphins; D010277:Parasympathomimetics; D011976:Receptors, Muscarinic; D011978:Receptors, Nicotinic; D009388:Neostigmine; D010830:Physostigmine; D000109:Acetylcholine